SCHEMBL6621499

SCHEMBL6621499

c1ccc(-c2ccc(COC3CNCCC3c3ccoc3)cc2)cc1.c1ccc2cc(COC3CNCCC3c3ccoc3)ccc2c1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 19/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4873205 0.94 REN (0.70) REN
SCHEMBL14256322 0.94 REN (0.70) REN
SCHEMBL14256321 0.92 REN (0.52) REN
SCHEMBL4872789 0.92 REN (0.52) REN
SCHEMBL6632191 0.88 REN (0.80) REN
SCHEMBL4873583 0.85 REN (0.55) REN
SCHEMBL14256320 0.85 REN (0.55) REN
SCHEMBL4865984 0.84 REN (0.54) REN
SCHEMBL14256324 0.84 REN (0.54) REN
SCHEMBL13126342 0.84 REN (0.70) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448200-A2 (4-PHENYL)PIPERIDIN-3-YL-PHENYLCARBOXYLATE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-08-25 EP claimed
WO-2003043987-A2 (4-PHENYL) PIPERIDIN-3-YL-PHENYLCARBOXYLATE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2003-05-30 WO claimed